Skip to content
Agentic OS
Menu

Intelligence / Services / Auditor Changes / Hepion Pharmaceuticals, Inc.

Auditchanged auditor (SEC 8-K)28 Sept 2026

Hepion Pharmaceuticals, Inc.

28 Sept 2026: Changed auditor (SEC 8-K) · Grassi & Co., CPAs. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
28 Sept 2026
Ticker
HEPA
Sector
Pharma and biotech
Sic
2834
Items
4.01, 9.01
Location
Red Bank, NJ
State
New Jersey
Country
United States
SEC CIK
1583771
Reference
0001493152-26-044432
Former
Grassi & Co., CPAs
Event
Auditor dismissed
What this signal means

A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.

  1. Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
  2. 22 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Hepion Pharmaceuticals, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.

Start free

Across AOS Research

Other records for Hepion Pharmaceuticals, Inc. in our registers.

More in Auditor dismissed

Auditor Changes

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.